We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04892953
Brief Title: Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

First Submitted : May 5, 2021
First Submitted that Met QC Criteria : May 14, 2021
First Posted : May 19, 2021

Last Update Submitted that Met QC Criteria : December 13, 2022
Last Update Posted : December 15, 2022